Su Young Kim

624 total citations
12 papers, 237 citations indexed

About

Su Young Kim is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Su Young Kim has authored 12 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Genetics. Recurrent topics in Su Young Kim's work include Acute Lymphoblastic Leukemia research (5 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Cancer Treatment and Pharmacology (3 papers). Su Young Kim is often cited by papers focused on Acute Lymphoblastic Leukemia research (5 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Cancer Treatment and Pharmacology (3 papers). Su Young Kim collaborates with scholars based in United States, Australia and United Kingdom. Su Young Kim's co-authors include David M. Scher, Jeffrey A. Toretsky, Lee J. Helman, Jeong Sook Park, Mary Ann Anderson, William G. Wierda, Martin Dunbar, Ming Zhu, Thomas J. Kipps and Soham D. Puvvada and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Oncologist.

In The Last Decade

Su Young Kim

12 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su Young Kim United States 7 109 77 75 62 50 12 237
Gregory Malnassy United States 9 147 1.3× 71 0.9× 86 1.1× 34 0.5× 17 0.3× 14 271
C. Massard France 11 141 1.3× 87 1.1× 21 0.3× 11 0.2× 130 2.6× 40 325
Ting‐Yan Shi China 7 270 2.5× 80 1.0× 60 0.8× 12 0.2× 41 0.8× 10 371
Juan Luiz Coelho‐Silva Brazil 10 155 1.4× 43 0.6× 19 0.3× 54 0.9× 14 0.3× 35 264
Mihály Bak Hungary 12 152 1.4× 119 1.5× 24 0.3× 12 0.2× 56 1.1× 23 335
Jesús María Hernández-Sánchez Spain 11 95 0.9× 54 0.7× 42 0.6× 72 1.2× 14 0.3× 21 256
Enrica Antonia Martino Italy 12 183 1.7× 121 1.6× 28 0.4× 58 0.9× 24 0.5× 60 417
Mara Mazzoni Italy 10 196 1.8× 117 1.5× 23 0.3× 13 0.2× 59 1.2× 14 330
Desmond Robb Canada 7 91 0.8× 141 1.8× 87 1.2× 13 0.2× 20 0.4× 9 328
Matteo Capaia Italy 12 112 1.0× 114 1.5× 80 1.1× 103 1.7× 77 1.5× 14 384

Countries citing papers authored by Su Young Kim

Since Specialization
Citations

This map shows the geographic impact of Su Young Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Young Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Young Kim more than expected).

Fields of papers citing papers by Su Young Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Young Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Young Kim. The network helps show where Su Young Kim may publish in the future.

Co-authorship network of co-authors of Su Young Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Su Young Kim. A scholar is included among the top collaborators of Su Young Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Young Kim. Su Young Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kim, Su Young & Jeong Sook Park. (2021). The Effect of Self-Acupressure on Peripheral Neuropathy, Disturbance in Daily Activity, and Quality of Life in Breast Cancer Patients undergoing Chemotherapy. Asian Oncology Nursing. 21(3). 129–129. 9 indexed citations
2.
Thiéblemont, Catherine, Michael Roost Clausen, Anna Sureda, et al.. (2021). Phase 3 trial (GCT3013-05) of epcoritamab versus standard of care in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).. Journal of Clinical Oncology. 39(15_suppl). TPS7569–TPS7569. 3 indexed citations
3.
4.
Salem, Ahmed Hamed, Mohamed Badawi, Andrew E. Place, et al.. (2020). Venetoclax Crosses the Blood Brain Barrier: A Pharmacokinetic Analysis of the Cerebrospinal Fluid in Pediatric Leukemia Patients. Blood. 136(Supplement 1). 30–31. 6 indexed citations
5.
Chyla, Brenda, Relja Popovic, Charles Lu, et al.. (2019). Identification of Recurrent Genomic Alterations in the Apoptotic Machinery in CLL Patients Treated with Venetoclax Monotherapy. Blood. 134(Supplement_1). 172–172. 3 indexed citations
6.
Place, Andrew E., Kelly C. Goldsmith, Jean‐Pierre Bourquin, et al.. (2018). Accelerating Drug Development in Pediatric Cancer: A Novel Phase I Study Design of Venetoclax in Relapsed/Refractory Malignancies. Future Oncology. 14(21). 2115–2129. 39 indexed citations
7.
Hantel, Andrew, Joseph Wynne, Norman J. Lacayo, et al.. (2018). Safety and Efficacy of the BCL Inhibitors Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 18. S184–S185. 7 indexed citations
8.
Alexander, Thomas, Seong Lin Khaw, Jeffrey E. Rubnitz, et al.. (2018). Open-label, dose-escalation, phase 1 study of venetoclax in combination with navitoclax and chemotherapy in patients with relapsed acute lymphoblastic leukemia.. Journal of Clinical Oncology. 36(15_suppl). TPS10575–TPS10575. 1 indexed citations
9.
Davids, Matthew S., Andrew W. Roberts, John F. Seymour, et al.. (2017). Venetoclax (VEN) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL).. Journal of Clinical Oncology. 35(15_suppl). e19041–e19041. 1 indexed citations
10.
Gerecitano, John F., Andrew W. Roberts, John F. Seymour, et al.. (2015). A Phase 1 Study of Venetoclax (ABT-199 / GDC-0199) Monotherapy in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma. Blood. 126(23). 254–254. 60 indexed citations
11.
Kim, Su Young, Jeffrey A. Toretsky, David M. Scher, & Lee J. Helman. (2009). The Role of IGF-1R in Pediatric Malignancies. The Oncologist. 14(1). 83–91. 78 indexed citations
12.
Lee, Jong Woo, Young Hwa Soung, Su Young Kim, et al.. (2005). Mutational analysis of the ARAF gene in human cancers. Apmis. 113(1). 54–7. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory Malnassy Breakdown of academic impact, for papers by C. Massard Breakdown of academic impact, for papers by Ting‐Yan Shi Breakdown of academic impact, for papers by Juan Luiz Coelho‐Silva Breakdown of academic impact, for papers by Mihály Bak Breakdown of academic impact, for papers by Jesús María Hernández-Sánchez Breakdown of academic impact, for papers by Enrica Antonia Martino Breakdown of academic impact, for papers by Mara Mazzoni Breakdown of academic impact, for papers by Desmond Robb Breakdown of academic impact, for papers by Matteo Capaia
Rankless by CCL
2026